TRANSLATE BIO INC's ticker is TBIO and the CUSIP is 89374L104. A total of 133 filers reported holding TRANSLATE BIO INC in Q2 2020. The put-call ratio across all filers is 0.77 and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2021 | $23,000 | +76.9% | 1,416 | +94.2% | 0.00% | 0.0% |
Q4 2020 | $13,000 | -35.0% | 729 | -50.2% | 0.00% | -50.0% |
Q3 2020 | $20,000 | -25.9% | 1,463 | -4.1% | 0.00% | -33.3% |
Q2 2020 | $27,000 | – | 1,526 | +2443.3% | 0.00% | – |
Q4 2019 | $0 | -100.0% | 60 | -99.4% | 0.00% | -100.0% |
Q2 2018 | $128,000 | – | 10,128 | – | 0.04% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Atlas Venture Advisors, Inc. | 3,922,008 | $39,102,000 | 52.94% |
Omega Fund Management, LLC | 2,437,603 | $24,303,000 | 10.06% |
Baupost Group | 17,544,239 | $171,071,000 | 2.52% |
FRAZIER MANAGEMENT LLC | 2,182,789 | $21,762,000 | 2.47% |
RTW INVESTMENTS, LP | 3,692,424 | $36,813,000 | 1.58% |
Camber Capital Management LP | 1,765,000 | $17,597,000 | 1.05% |
Bain Capital Public Equity Management II, LLC | 416,670 | $4,154,000 | 0.49% |
Rock Springs Capital Management LP | 825,000 | $8,225,000 | 0.34% |
Birchview Capital, LP | 30,000 | $299,000 | 0.26% |
Artal Group S.A. | 600,000 | $5,982,000 | 0.25% |